Male pattern baldness and its management: an update.
Androgenetic alopecia (AGA) sometimes referred to as `male pattern baldness' (MPB) may affect up to 50% of males between the ages of 30 and 50 years. The authors of this article review the medical and surgical approaches currently available to treat AGA. Medications, such as topical minoxidil, which are currently being marketed as a treatment for AGA, as well as other drugs currently under investigation are examined. Recent advances in punch hair transplantation, alopecia reductions, and flap surgery are also discussed.
P C
PC
Cotterill
W P
WP
Unger
Plast Reconstr Surg. 1975 Apr;55(4):456-60
1090958
Lancet. 1987 May 2;1(8540):1019-22
2883354
Ann N Y Acad Sci. 1951 Mar;53(3):708-28
14819896
Clin Exp Dermatol. 1984 Jul;9(4):342-50
6235065
J Invest Dermatol. 1984 Jan;82(1):90-3
6197493
J Am Acad Dermatol. 1985 Mar;12(3):586-7
3989020
Dermatologica. 1986;173(3):136-8
3770260
J Invest Dermatol. 1983 Dec;81(6):558-60
6196423
J Dermatol Surg Oncol. 1984 Dec;10(12):967-9
6501688
Lancet. 1979 Aug 11;2(8137):304-5
88632
Dermatologica. 1980;160(6):398-404
6446466
J Dermatol Surg Oncol. 1984 Jan;10(1):12-4
6537812
J Invest Dermatol. 1984 May;82(5):515-7
6239893
J Am Acad Dermatol. 1986 Oct;15(4 Pt 2):880-3, 890-3
3771854
Dermatologica. 1980;161(2):124-32
7398983
Br J Dermatol. 1979 Nov;101(5):593-5
518830